FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

30937411000001104: Sebelipase alfa 20mg/10ml solution for infusion vials (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 11-Nov 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
95549801000001118 Sebelipase alfa 20mg/10ml solution for infusion vials (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
95549901000001112 Sebelipase alfa 20mg/10ml solution for infusion vials en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sebelipase alfa 20mg/10ml solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route solutioninfusion.intravenous ontology form and route true Inferred relationship Existential restriction modifier
Sebelipase alfa 20mg/10ml solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Sebelipase alfa 20mg/10ml solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Sebelipase alfa 20mg/10ml solution for infusion vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Intravenous route true Inferred relationship Existential restriction modifier
Sebelipase alfa 20mg/10ml solution for infusion vials Is a Sebelipase alfa true Inferred relationship Existential restriction modifier
Sebelipase alfa 20mg/10ml solution for infusion vials Is a Sebelipase alfa false Inferred relationship Existential restriction modifier
Sebelipase alfa 20mg/10ml solution for infusion vials Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Sebelipase alfa 20mg/10ml solution for infusion vials Has specific active ingredient Sebelipase alfa false Inferred relationship Existential restriction modifier
Sebelipase alfa 20mg/10ml solution for infusion vials VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Sebelipase alfa 20mg/10ml solution for infusion vials VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Sebelipase alfa 20mg/10ml solution for infusion vials Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Sebelipase alfa 20mg/10ml solution for infusion vials Has manufactured dose form Conventional release solution for infusion false Inferred relationship Existential restriction modifier
Sebelipase alfa 20mg/10ml solution for infusion vials Has specific active ingredient Sebelipase alfa true Inferred relationship Existential restriction modifier
Sebelipase alfa 20mg/10ml solution for infusion vials Has active ingredient Substance with enzyme mechanism of action false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Kanuma 20mg/10ml concentrate for solution for infusion vials (Alexion Pharma UK Ltd) Is a True Sebelipase alfa 20mg/10ml solution for infusion vials Inferred relationship Existential restriction modifier
Sebelipase alfa 20mg/10ml solution for infusion vials 1 vial Has VMP True Sebelipase alfa 20mg/10ml solution for infusion vials Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start